HDTRA120C0045

APPLICATION OF A NANOCOMPLEX TECHNOLOGY TO THE ACTIVE PERMEATION OF THE BLOOD BRAIN BARRIER (BBB)

Defense Threat Reduction Agency · United States

This tender closed on Sunday, July 6, 2025. Browse open opportunities

View Source

Time Left to Bid

Closed

ClosedDefence & SecurityFederal

Basic information

Reference number: HDTRA120C0045
Issuing organization: Defense Threat Reduction Agency · Find award history →
Government level: Federal
Solicitation type: Defence & Security
Title: APPLICATION OF A NANOCOMPLEX TECHNOLOGY TO THE ACTIVE PERMEATION OF THE BLOOD BRAIN BARRIER (BBB)
Source: USASpending (Federal)
Source ID: usa-HDTRA120C0045

Details

Location: United States

Description

APPLICATION OF A NANOCOMPLEX TECHNOLOGY TO THE ACTIVE PERMEATION OF THE BLOOD BRAIN BARRIER (BBB) Awarded to: SYNERGENE THERAPEUTICS INC Agency: Department of Defense Sub-agency: Defense Threat Reduction Agency Award type: DEFINITIVE CONTRACT

Dates

Publication: 2020/07/07 12:00:00 AM UTC
Closing date: 2025/07/06 12:00:00 AM UTC

Estimated value

$7.6M USD

Classification

Normalized category

Defence & Security

Source: USASpending (Federal)

Last updated 2026-05-25, 2:30:02 p.m.

Data refreshed every 2 hours